立即開始
jhains2

AKAO Rounding Bottom in Place Ahead of 6/25 FDA Meeting Date

看多
jhains2  
NASDAQ:AKAO   None
Chart Patterns Beyond Technical Analysis
1
0
chartpattern beyondta
The FDA will consider AKAO's lead drug on June 25th.

The stock appears to have put in a solid bottom ahead of that meeting.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。